The COVID-19 Antigen Lateral Flow Assay is a lateral flow immunoassay intend for the qualitative detection SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider.
Name COVID-19 Antigen Lateral Flow Assay
Method Lateral Flow Assay
Sample type Nasopharyngeal Swab/Oropharyngeal Swab Sample
Specification 20 Tests/Kit
Detection time 15 min
Detection objects Novel Coronavirus
Stability The kit is stable for 1 years at 2℃-30℃
Rapid: Obtain result within 15 min.
Simple: Easy to use, without complicated operation.
Intuitive result: There is no need for calculation and instrument, visual reading results.
Economic: Product can be transported and stored at room temperature, reducing costs.
Low risk: Testing swab sample, reducing the risk of sampling process.
COVID-19 Antigen Lateral Flow Assay: VAgLFA-01:20 tests/kit